Table 1.

Body weight and glucose metabolism at the end of experimental periods.

Metabolic Parameters	AD-Con	AD-TTK	Normal-Con
Body weight (g)	398 ± 6.7	410 ± 6.2	411 ± 15.4
Weight gain (g)	188 ± 7.6	210 ± 5.2	208 ± 13.8
Food intake (g)	16.8 ± 1.2	17.8 ± 1.3	17.4 ± 1.5
Fasting serum glucose	106 ± 8.3	105 ± 5.6	110 ± 5.1
Fasting serum insulin	1.16 ± 0.31	1.08 ± 0.25	1.06 ± 0.27

Values represent means ± standard deviations. AD and non-AD rats infused amyloid-β(25–35) into the CA1 regions and amyloid-β(35–25) into the CA1 regions, respectively. AD-Con fed 45% fat diet with 0.5% dextrin in AD rats having the intra-CA1 infusion of amyloid-β(25–35); AD-TTK, fed 45% fat diet with 0.5% water extract of Tetragonia tetragonioides (TTK) in AD rats, and Normal-Con fed 45% fat diet with 0.5% dextrin in non-AD rats having the intra-CA1 infusion of amyloid-β(35–25).